Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

New England Journal of Medicine

Volumn 318, Issue 14, 1988, Pages 869-876

  Brandt, Stephen J ^a   Peters, William P ^a   Atwater, Susan K ^a   Kurtzberg, Joanne ^a   Borowitz, Michael J ^a   Jones, Roy B ^a   Shpall, Elizabeth J ^a   Bast, Robert C ^a   Gilbert, Colleen J ^a   Oette, Dagmar H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FLUID RETENTION; HEMATOPOIESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYALGIA; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0023905962     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198804073181401     Document Type: Article

References (34)

1. Pizzo PA. Granulocytopenia and cancer therapy: past problems, current solutions, future challenges. Cancer 1984; 54: 2649–61.
2. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345–51.
3. Herzig GP. Autologous marrow transplantation in cancer therapy. Prog Hematol 1981; 12: 1–23.
4. Souhami R, Peters W. High dose chemotherapy in solid tumours in adults. Clin Haematol 1986; 15: 219–34.
5. Phillips GL, Herzig RH, Lazarus HM, et al. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med 1984; 310: 1557–61.
6. Peters WP, Eder JP, Henner WD, et al. High-dose combination alkylating agents with autologous bone marrow support: a phase 1 trial. J Clin Oncol 1986; 4: 646–54.
7. Peters WP, Eder JP, Henner WD, Bast RC, Schnipper L, Frei E. Novel toxicities associated with high dose combination alkylating agents and autologous bone marrow support. In: Dicke KA, Spitzer G, Zander AR, eds. Autologous bone marrow transplantation. Proceedings of the First International Symposium, August 1984. Houston: University of Texas, MD Anderson Hospital, 1985:189–95.
8. Wong GG, Witek JS, Temple PA, et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810–5.
9. Lee F, Yokota T, Otsuka T, et al. Isolation of cDNA for a human granulocyte–macrophage colony-stimulating factor by functional expression in mammalian cells. Proc Natl Acad Sci USA 1985; 82: 4360–4.
10. Kaushansky K, O'Hara PJ, Berkner K, Segal GM, Hagen FS, Adamson JW. Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocytemacrophage colony-stimulating factor. Proc Natl Acad Sci USA 1986; 83: 3101–5.
11. Nagata S, Tsuchiya M, Asano S. et al. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986; 319: 415–8.
12. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–5.
13. Kawasaki ES, Ladner MB, Wang AM, et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985; 230: 291–6.
14. Wong GG, Temple PA, Leary Achéal, et al. Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 1987; 235: 1504–8.
15. Yang Y-C, Ciarletta AB, Temple PA, et al. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986; 47: 3–10.
16. Dorssers L, Burger H, Bot F, et al. Characterization of a human multilineage-colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3. Gene 1987; 55: 115–24.
17. Sieff CA. Hematopoietic growth factors. J Clin Invest 1987; 79: 1549–57.
18. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–37.
19. Donahue RE, Wang EA, Stone DK, et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872–5.
20. Nienhuis AW, Donahue RE, Karlsson S, et al. Recombinant human granulocytemacrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 1987; 80: 573–7.
21. Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW. Effect of recombinant human granulocyte–macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 593–8.
22. Sieff CA, Emerson SG, Donahue RE, et al. Human recombinant granulocytemacrophage colony-stimulating factor: a multilineage hematopoietin. Science 1985; 230: 1171–3.
23. Mayer P, Lam C, Obenaus H, Liehl E, Besemer J. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorpho-nuclear neutrophils in nonhuman primates. Blood 1987; 70: 206–13.
24. Testa NG, Hendry JH, Molineux G. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. Anticancer Res 1985; 5: 101–10.
25. Lohrmann H-P, Schreml W, Lang M, Betzler M, Fliedner TM, Heimpel H. Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer. Br J Haematol 1978; 40: 369–81.
26. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multiple-organfailure syndrome. Arch Surg 1986; 121: 196–208.
27. Lotze MT, Matory YL, Rayner AA, et al. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer 1986; 58: 2764–72.
28. Rosenstein M, Ettinghausen SE, Rosenberg SA. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol 1986; 137: 1735–42.
29. Morrissey PJ, Bressler L, Park LS, Alpert A. Gillis S. Granulocytemacrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J Immunol 1987; 139: 1113–9.
30. Küpper T, Flood P, Coleman D, Horowitz M. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocytemacrophage colony-stimulating factor (GM-CSF). J Immunol 1987; 138: 4288–92.
31. Woods A, West J, Rasmussen R, Bottomly K. Granulocytemacrophage colony stimulating factor produced by cloned L3T4a+, class II-restricted T cells induce HT-2 cells to proliferate. J Immunol 1987; 138: 4293–7.
32. Baldwin GC, DiPersio J, Kaufman SE, Quan SG, Golde DW, Gasson JC. Characterization of human GM-CSF receptors on non-hematopoietic cells. Blood 1987; 70: 166a. abstract.
33. Ruff MR, Farrar WL, Pert CB. Interferon y and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines. Proc Natl Acad Sci USA 1986; 83: 6613–7.
34. Munker M, Munker R, Saxton RE, Koeffler HP. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines. Cancer Res 1987; 47: 4081–5.